PERSPECTA

News from every angle

Back to headlines

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

Eli Lilly is reportedly considering re-entering the bidding process for Abivax, contingent on whether AstraZeneca fails to meet its acquisition deadline.

14 Mar, 03:30 — 14 Mar, 03:30
PostShare

Sources

Showing 1 of 1 sources